FDA Lifts Hold on Concert Pharma's Study Testing Hair Loss Drug

Concert Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration (FDA) lifted a clinical hold on a trial testing its therapy for alopecia areata, a type of hair loss.
Reuters Health Information

http://ift.tt/2t056E1